Clinical study on the chemotherapy of multiple myeloma. 1. Therapeutic effect of sequential combination therapy using melphalan, ifosfamide, and prednisolone
Sezaki, T.; Ishii, H.; Osada, T.; Adachi, T.; Takahashi, I.; Ohnoshi, T.; Kimura, I.
Japanese Journal of Clinical Hematology 23(6): 847-853
1982
ISSN/ISBN: 0485-1439
PMID: 7176091
Accession: 042576030
PDF emailed within 1 workday: $29.90
Related References
Adachi, T.; Asano, K.; Sezaki, T.; Takahashi, I.; Kimura, I. 1982: Prognostic factors in multiple myeloma treated with prednisolone and sequential melphalan and ifosfamide prednisolone and sequential melphalan and ifosfamide combination chemo therapy Acta Medica Okayama 36(1): 39-48Sezaki, T.; Ishii, H.; Adachi, T.; Takahashi, I.; Ohnoshi, T.; Kimura, I. 1983: Clinical study on chemotherapy for multiple myeloma. Part II: Prognostic factors of treatment with prednisolone and sequential melphalan and ifosfamide: MIP therapy Japanese Journal of Clinical Hematology 24(4): 433-439
Adachi, T.; Asano, K.; Sezaki, T.; Takahashi, I.; Kimura, I. 1982: Prognostic factors in multiple myeloma treated with prednisolone and sequential melphalan and ifosfamide: MIP combination chemotherapy Acta Medica Okayama 36(1): 39-47
Adachi, T. 1981: Clinical studies on chemo therapy for multiple myeloma 2. response rates prognostic factors and side effects in multiple myeloma treated with prednisolone and sequential melphalan and ifosfamide Okayama Igakkai Zasshi 93(5-6): 519-536
Ishii, H. 1988: Combination chemotherapy for multiple myeloma with melphalan, ifosfamide, prednisolone, nitrosourea and vincristine Acta Medica Okayama 42(3): 175-182
Suzuki, K.; Doki, N.; Meguro, K.; Sunami, K.; Kosugi, H.; Sasaki, O.; Takagi, T.; Murakami, H.; Shimizu, K. 2019: Report of phase I and II trials of melphalan, prednisolone, and thalidomide triplet combination therapy versus melphalan and prednisolone doublet combination therapy in Japanese patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplantation International Journal of Hematology 110(4): 447-457
Glueck, S.; Schoppe, W.D.; Schneider, W. 1986: Vincristine cyclophosphamide melphalan prednisolone chemotherapy of multiple myeloma after ineffective melphalan prednisolone therapy Blut 53(3): 227
Imamura, Y.; Takagi, T.; Yawata, Y.; Nishinarita, S.; Kosaka, M.; Mikuni, C.; Takatsuki, K.; Sezaki, T.; Mori, M.; Tsuchiya, J. 1994: Combination chemotherapy with MCNU, vindesine, melphalan, and prednisolone (MCNU-VMP therapy) in induction therapy for multiple myeloma. Japan Myeloma Study Group International Journal of Hematology 59(2): 113-123
Ishii, H. 1988: M-protein kinetics in multiple myeloma treated with melphalan, ifosfamide, prednisolone, nitrosourea and vincristine in combination Acta Medica Okayama 42(5): 279-286
Chou, T.; Tobinai, K.; Uike, N.; Asakawa, T.; Saito, I.; Fukuda, H.; Mizoroki, F.; Ando, K.; Iida, S.; Ueda, R.; Tsukasaki, K.; Hotta, T.; Aikawa, K.; Matsuda, S.; Nakata, M.; Oshimi, K.; Ohmachi, K.; Ohnishi, K.; Kinoshita, T.; Okamura, S.; Tsukada, J. 2011: Melphalan-prednisolone and vincristine-doxorubicin-dexamethasone chemotherapy followed by prednisolone/interferon maintenance therapy for multiple myeloma: Japan Clinical Oncology Group Study, JCOG0112 Japanese Journal of Clinical Oncology 41(4): 586-589
Takagi, T.; Oguro, M.; Sakai, C. 1986: Combination chemotherapy with melphalan, cyclophosphamide, vincristine, ACNU and prednisolone (MEV(Ac)P) for multiple myeloma Japanese Journal of Clinical Hematology 27(12): 2249-2253
Steinke, B.; Busch, F.W.; Stapelfeld, S.; Ostendorf, P.; Waller, H.D. 1984: Therapy of multiple myeloma. Results of sequential treatment with melphalan-prednisolone and the M2 protocol Deutsche Medizinische Wochenschrift 109(26): 1015-1019
Adachi, T. 1981: Clinical studies on chemo therapy for multiple myeloma 1. response rates and survival times in multiple myeloma treated with melphalan and ifosfamide Okayama Igakkai Zasshi 93(5-6): 507-518
Gregory, W.M.; Richards, M.A.; Malpas, J.S. 1992: Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 10(2): 334-342
Majumdar, G.; Ganguly, K.; Kashyap, S.; Bardhan, G. 1998: Cyclophosphamide-idarubicin-dexamethasone An effective oral combination chemotherapy for melphalan-prednisolone resistant multiple myeloma British Journal of Haematology 102(1): 352